Cargando…
Estimated Health Outcomes and Costs of COVID-19 Prophylaxis With Monoclonal Antibodies Among Unvaccinated Household Contacts in the US
IMPORTANCE: The COVID-19 pandemic has led to more than 900 000 deaths in the US and continues to disrupt lives even as effective vaccines are available. OBJECTIVE: To estimate the health outcomes and net cost of implementing postexposure prophylaxis (PEP) with monoclonal antibodies (mAbs) against ho...
Autores principales: | Flaxman, Abraham D., Issema, Rodal, Barnabas, Ruanne V., Ross, Jennifer M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034404/ https://www.ncbi.nlm.nih.gov/pubmed/35452104 http://dx.doi.org/10.1001/jamanetworkopen.2022.8632 |
Ejemplares similares
-
997. Protection of Unvaccinated Individuals by Influenza Vaccine Coverage of Household Contacts
por: Malosh, Ryan E, et al.
Publicado: (2018) -
Health Outcomes and Cost-effectiveness of Monoclonal SARS-CoV-2 Antibodies as Pre-exposure Prophylaxis
por: Popping, Stephanie, et al.
Publicado: (2023) -
Frequency of HIV serodifferent couples within TB-affected households in a setting with a high burden of HIV-associated TB
por: Anguzu, Godwin, et al.
Publicado: (2023) -
Pertussis Post-Exposure Prophylaxis among Household Contacts: A Cost-Utility Analysis
por: Thampi, Nisha, et al.
Publicado: (2015) -
Estimated COVID-19 Cases and Hospitalizations Averted by Case Investigation and Contact Tracing in the US
por: Rainisch, Gabriel, et al.
Publicado: (2022)